Generic Medicine Archives

Partner with a Leading Third-party Generic Medicine Manufacturer for Mongolia

JoinHub Pharma is an award-winning manufacturer, supplies, and exporter of third-party generic medicines for Mongolia. When it comes to generic and branded medications, we have a proven record.

What makes us the greatest choice for you to associate with and become our client? Here are a couple of things to consider:

Featured in prestigious pharmaceutical publications
The latest and most advanced packaging technology, such as ALU-ALU, is employed.
The Manufacturing Agreement is maintained in a transparent manner by clarifying the terms & conditions. It additionally covers intellectual property rights, tenure and early termination fees, and other payment terms information.
We have an excellent reputation for maintaining long-term relationships.
Largest selection of over 1300 pharmaceutical goods.
Distinct departments dedicated to various parts of healthcare and medicines.
Skilled R&D team with a well-equipped laboratory.
Our Manufacturing occurs in duty-free excise zones, lowering the cost of the commercial transaction.
All drugs are approved by FDA.
All pharmaceutical items are FSSAI and DCGI certified.
Units and factories that have been authorized by respectable organizations like the World Health Organization (WHO) and Good Manufacturing Practices (GMP) (GMP).
All generic medication product formulas for clients are kept strictly secret.
The pharmaceutical company is in charge of approving an Abbreviated New Drug Application (ANDA) for the commercialization of a generic drug product.

Partner With An Award-Winning Quality Pharma Company | JoinHub Pharma

Do you need a reliable third-party generic medication manufacturer for Mongolia? Looking for the perfect business deal?

JoinHub Pharma is a leading third-party manufacturer of generic medicines for Mongolia. We manufacture pharma products for a variety of clients, including big-name pharmaceutical companies for Mongolia and private label companies. We have been in the pharma business for many years and are ISO 9001 certified.

Our WHO-GMP-approved manufacturing facilities are located in India. We also have a distribution network that allows us to deliver our products within 24 hours anywhere in the world.

JoinHub Pharma offers competitive pricing, fast turnaround time, and superior quality products that meet all FDA requirements.

Our company has far outreached the needs and demands of consumers for Mongolia, which helped us earn a name of being patient-centric. All thanks to our highly skilled and experienced Research & Development team.

Our main goal is to ensure our customers can focus on what they do best: running their businesses! Our team is dedicated to providing quality service, so you don’t have to worry about anything other than running your company while we take care of everything else!

Generic Pharma Drugs Being Manufactured By JoinHub Pharma

JoinHub Pharma is the proud owner of over 1300 pharmaceutical products. We cover a wide range of healthcare issues such as derma, dentistry, eye vision, paediatrics, and sexual wellness.

When producing generic pharmaceuticals, we used the most recent packaging technology. JoinHub Pharma manufactures the following generic pharmaceutical drugs within the category:

Tablets
Drops
Ointment
Capsules
Sachets
Lotions
Powders
Syrups
Much more

Our organization guarantees the purity and longevity of generic medications. We guarantee the finest results. Our R&D department will be responsible for the creation of generic medicine. You can reach out to us at [email protected].

Safe and Effective Generic Drug Manufacturing for Mongolia

JoinHub Pharma is a Safe and effective third-party generic medicine manufacturer for Mongolia. JoinHub Pharma produces generic medicines for all major therapeutic areas, including infectious diseases, cardiovascular, dermatology, gastroenterology, diabetes, and respiratory diseases. JoinHub Pharma has many active generic programs in development, covering over 1300 products.

We are committed to our products’ quality and strive to provide affordable medicines that meet or exceed international standards. Our pharma products are made in our own facilities with the highest quality materials. Our manufacturing practices are certified by the FDA, WHO, and ISO. We also have a robust testing program in place to ensure that each batch meets all relevant regulatory requirements.

We have a broad range of expertise: we can help you develop a new product or improve an existing one, handle all aspects of clinical research and development, perform regulatory submissions for approval, manage the manufacturing process from beginning to end, supply finished goods directly to your customers or offer distribution services through our network of distributors around the world.

Why choose JoinHub Pharma for Generic Medicine Manufacturing for Mongolia?

Generic drugs are made available for purchase once the patents on the original medicines expire, and only if they meet FDA criteria. As a result, as a leading generic pharmaceutical manufacturer for Mongolia, we strictly adhere to all such regulations.

Apart from being ISO, FDCA-INDIA, and WHO cGMP accredited, our production facilities rigorously adhere to the GMP requirements outlined in the “Revised Schedule M” by the Drug Controller (General) India, Ministry of Health, and Government of India.

JoinHub Pharma rigorously adheres to the following requirements for the production of our generic medications, which has earned us a fabulous reputation as a top third-party generic pharmaceutical manufacturing firm for Mongolia:

Higher criteria for testing sessions
Use of high-efficiency components
Higher purity of active and inactive substances
High storage standards

JoinHub Pharma is a leading third-party generic medicine manufacturer for Mongolia. We believe everyone deserves easy access to top-notch quality healthcare, so we’re committed to making sure our medicines are accessible as possible.

We specialize in providing high-quality, affordable generic medicines to customers around the world.

Simply drop us your requirement via email at [email protected], and our pharma experts will reach out to you!

Generic Medicine

Partner with a Leading Third-Party Generic Medicine Manufacturer for Mongolia

by Join Hub Pharma on December 5, 2022

JoinHub Pharma is an award-winning manufacturer, supplies, and exporter of third-party generic medicines for Mongolia. When it comes to generic and branded medications, we have a proven record.

What makes us the greatest choice for you to associate with and become our client? Here are a couple of things to consider:

Featured in prestigious pharmaceutical publications
The latest and most advanced packaging technology, such as ALU-ALU, is employed.
The Manufacturing Agreement is maintained in a transparent manner by clarifying the terms & conditions. It additionally covers intellectual property rights, tenure and early termination fees, and other payment terms information.
We have an excellent reputation for maintaining long-term relationships.
Largest selection of over 1300 pharmaceutical goods.
Distinct departments dedicated to various parts of healthcare and medicines.
Skilled R&D team with a well-equipped laboratory.
Our Manufacturing occurs in duty-free excise zones, lowering the cost of the commercial transaction.
All drugs are approved by FDA.
All pharmaceutical items are FSSAI and DCGI certified.
Units and factories that have been authorized by respectable organizations like the World Health Organization (WHO) and Good Manufacturing Practices (GMP) (GMP).
All generic medication product formulas for clients are kept strictly secret.
The pharmaceutical company is in charge of approving an Abbreviated New Drug Application (ANDA) for the commercialization of a generic drug product.

Partner With An Award-Winning Quality Pharma Company | JoinHub Pharma

Do you need a reliable third-party generic medication manufacturer for Mongolia? Looking for the perfect business deal?

Our WHO-GMP-approved manufacturing facilities are located in India. We also have a distribution network that allows us to deliver our products within 24 hours anywhere in the world.

JoinHub Pharma offers competitive pricing, fast turnaround time, and superior quality products that meet all FDA requirements.

Generic Pharma Drugs Being Manufactured By JoinHub Pharma

JoinHub Pharma is the proud owner of over 1300 pharmaceutical products. We cover a wide range of healthcare issues such as derma, dentistry, eye vision, paediatrics, and sexual wellness.

When producing generic pharmaceuticals, we used the most recent packaging technology. JoinHub Pharma manufactures the following generic pharmaceutical drugs within the category:

Tablets
Drops
Ointment
Capsules
Sachets
Lotions
Powders
Syrups
Much more

Safe and Effective Generic Drug Manufacturing for Mongolia

JoinHub Pharma is a Safe and effective generic medicine manufacturer. JoinHub Pharma produces generic medicines for all major therapeutic areas, including infectious diseases, cardiovascular, dermatology, gastroenterology, diabetes, and respiratory diseases. JoinHub Pharma has many active generic programs in development, covering over 1300 products.

Why choose JoinHub Pharma for Generic Medicine Manufacturing for Mongolia?

Higher criteria for testing sessions
Use of high-efficiency components
Higher purity of active and inactive substances
High storage standards

We specialize in providing high-quality, affordable generic medicines to customers around the world.

Simply drop us your requirement via email at [email protected], and our pharma experts will reach out to you!

Generic Medicine pharmaceutical exporters

Why should you choose an Indian Generic medicine exporter for Ghana?

by Join Hub Pharma on October 17, 2022

According to the World Health Organization’s 2017 bulletin, worldwide “catastrophic health spending” pushes roughly 100 million people into poverty each year. Almost 90% of the population in low-income nations has financial issues due to healthcare costs. To raise awareness about this dire situation, WHO has declared the topic of this World Health Day, April 7, 2019, as ‘Health for All’ and has urged its member nations to join and support its UHC campaign. The goal is simple: lower growing healthcare costs while maintaining quality.

India is the world’s leading manufacturer of generic medicines.

The Indian pharmaceutical business meets more than half of the world’s demand for vaccines, 25% of all pharmaceuticals in the UK, and 40% of generic drug demand in the US. When a doctor prescribes a medicine, she will use either the brand or the generic name. The brand name is the name given to the medicine by its original creator or patent holder. A generic version of the same medicine has a different name, which is known as the generic name.

When medicine is created and meets the conditions for patentability, the applicant is given a patent for up to 20 years, providing the intellectual property owner a limited market exclusivity to recover their costs. After the patent expires, the medicine enters the public domain and is freely available for usage.

A generic medication is defined by the WHO as a pharmaceutical product that is typically interchangeable with the originator brand product, is made without a license from the originator manufacturer, and is marketed after the patent or other exclusivity rights have expired.

During the post-expiry period, other pharmaceutical companies may produce identical medicine and sell it under an international non-proprietary name – often at a cheaper cost. Because generics remove this obstacle to affordability, Indian law permits doctors to prescribe them to patients and pharmacists to sell them.

A generic medicine includes the same active ingredients as the branded version and produces the same therapeutic effects, regardless of their different colours, forms, tastes, or pricing.

Are generic prescriptions as safe and effective as brand-name prescriptions?

According to the FDA, all pharmaceuticals are made up of both brand names and generic drugs that should function well and be safe. Generic drugs have the same active components as their brand-name counterparts and carry the same risks and benefits. Many customers are concerned about the cost of generic medicines.

To ensure safety, quality, and effectiveness, the FDA subjected all generic pharmaceuticals to a thorough reassessment process that included a review of scientific information regarding the constituents and performance of the standard drug.

Furthermore, the FDA requires that a basic medication manufacturing plant satisfy the same high criteria as a location for a brand-name drug. Brand-name pharmaceutical businesses manufacture almost half of all generic medications. They can produce duplicates of their own or other companies’ brand pharmaceuticals and sell them without the brand name.

Benefits of importing Generic Medicine from Indian Generic Manufacturer, Exporter, Supplier for Ghana

Generic medication can be used to treat a variety of medical ailments. Some of the benefits of working with an Indian generic medications exporter for Ghana are as follows:

Generic drugs are less expensive

Buying generic drugs can help you save a lot of money. Generic medicines manufactured by Indian generic drug manufacturers are less expensive than non-generic drugs. These medications are less expensive because, unlike non-generic medications, they do not need to redo the active ingredient’s clinical studies.

Generic drugs include the same ingredients as non-generic medicines that are already authorized and approved. Another key method Indian generic pharmaceutical manufacturers and exporters for Ghana keep prices low is seldom spending money on promotion and marketing.

Generic drugs are safe and effective as their branded replicas

For patients, generic drug alternatives offer a safe and FDA-approved choice. In many ways, these medicines are similar to their brand-name counterparts, including dose, quality, potency, form, safety, intended use, and performance capabilities. The generic drug alternative is thought to be bioequivalent.

Duplicated Drugs are a Trusted Substitute for Brand-Name Drugs

Generic medication is bioequivalent to the more costly pharmaceuticals on the market because it is equally effective as its brand-name counterpart. Generic medications have the same dose, intended purpose, effects/side effects, dangers, safety, and strength as brand-name medications. Because the pharmacological effects of a copied drug are the same, about 90% of the US population prefers to purchase these drugs as a suitable alternative.

Your patients can readily discover generic substitutes

Patients in Ghana do not have to look far to find alternatives to many popular brand-name medications. Clients get access to a staggering quantity of respected prescriptions with high-quality generic medications.

Solves insurance coverage issues

Most health insurance policies that cover pharmaceutical drugs cater solely to a certain formulary or a list of brands whose medicines they will pay for. Any medicine not on that list or formulary must be paid for out of pocket, and you rarely receive the insurance benefit you deserve. In such a case, generic drugs can help you save money by lowering total health care costs or possibly lowering co-pay fees if generic medicines are covered.

JoinHub Pharma – A leading Generic Drug Manufacturer, Exporter, and Supplier for Ghana

JoinHub Pharma is also one of India’s top Generic Medicine Manufacturing firms. The pharma company has extensive experience in the manufacture of generic medications. Additionally, the pharma products created by JoinHub Pharma are of excellent quality and extremely effective. JoinHub Pharma’s whole product line is noted for its purity, excellent efficacy, and immediate alleviation. The main thing to remark about the company is that it is more concerned with improving people’s health than price.

Why Choose JoinHub Pharma as the best Indian Generic Medicine Manufacturer and Supplier for Ghana?

The following are the primary reasons for choosing JoinHub Pharma as the world’s best Indian Generic Medicine Manufacturer and Supplier for Ghana:

The company specializes in high-quality, low-cost pharmaceutical products.
The most crucial thing to remember about us is that we are more concerned with improving health than lowering prices.
We are a WHO-GMP certified manufacturing facility.
We collaborate with the customer to create the pharma range that meets their needs.

If you are looking for a reputed Indian Generic drug manufacturer and exporter for Ghana, look no further than JoinHub Pharma. We offer high-quality medicines at affordable rates.

Get in touch with our pharma experts for bulk orders.

Generic Medicine

Who is the Best Indian Generic Medicines Supplier for Syria?

by Join Hub Pharma on July 19, 2022

Rapidly rising healthcare expenses and high drug prices are a significant worry across the world, particularly in developing nations like Syria, where patients frequently have to pay the higher price of medicine.

Generic drugs are becoming more popular in a number of countries, including Syria, due to their cheaper cost while keeping the same efficacy as their original equivalents. However, some problems originate from a lack of information or misunderstanding of the idea of bioequivalence and from marketing efforts by manufacturers that persuade customers to return to branded pharmaceuticals.

Factors influencing affordability of medicine in Syria

The following factors tend to raise the cost of pharmaceuticals for patients:

Expensive launch costs, with medicine prices, frequently rising over time.
Inadequate competition aftermarket exclusivity is lifted.
The combination of market power, health insurance, and a lack of efficient price-control incentives.
Buyers and sellers have unequal negotiating power.
Expenses for research, development, marketing, and other commercial expenses.
Insurance benefit designs that include substantial patient cost-sharing clauses.
Poor performance of patient assistance programs and other governmental initiatives to make medications cheaper for patients.
Inadequate knowledge influences medication selection

Benefits of Generic Drugs

Generic medications include the same active components as brand-name pharmaceuticals in the same concentration. When a novel medicine is discovered, the pharmaceutical business that finds and markets it earns a patent on it. The patent is typically valid for 20 years, allowing the founding firm to repay its research investment. A generic version of the drug may become accessible when the patent expires.

Those who utilize generic pharmaceuticals in Syria are not alone; generic drugs account for 90% of prescriptions filled in the United States.

Learn more about the numerous benefits of generic medications now.

Generic medications can be just as effective as their brand-name counterparts.

For patients, generic medicine alternatives offer a viable and FDA-approved choice. In many ways, these medications are similar to their brand-name counterparts, including form, dose, potency, safety, quality, intended use, and performance qualities. The generic alternative is thought to be bioequivalent.

Generic drugs can help patients save a lot of money.

According to the FDA, generic pharmaceuticals can cost up to 85% less than the brand-name drugs they are meant to replace. How is this possible? The tests conducted with brand-name pharmaceuticals do not need to be redone with their bioequivalent generic alternative, which helps to reduce their cost significantly.

Generic drugs contribute to lower healthcare costs.

High-quality generic medications help more than just patients. The Association for Accessible Medicines said that generic pharmaceuticals had saved Syria’s healthcare system $1.67 trillion over the last decade. As healthcare prices continue to climb, it is critical to continue producing generic alternatives and making them available to patients. This may help decrease healthcare expenses frequently passed on to consumers.

Patients Can Easily Find a Generic Equivalent

Patients do not have to look far to obtain generic alternatives to many popular brand-name medications. Over 12,000 generic pharmaceuticals are accessible to customers, providing a surprisingly large number of popular treatments with high-quality generic versions. For example, Allegra allergy medicine can be replaced with Fexofenadine. Warfarin can be used in place of another common blood thinner, Coumadin.

Continue to Use Generics

Patients are three times more likely to quit branded medicines than generic alternatives, and this desertion is frequently linked to hefty co-pays. When it comes to assisting the many individuals who require prescription pharmaceuticals, generic drugs are an accessible and inexpensive choice that may boost the probability that patients adhere to doctor-recommended therapy.

JoinHub Pharma – Leading Generic medicine Manufacturer, Supplier, and Exporter

JoinHub Pharma is a high-quality pharmaceutical manufacturing company. When it comes to the biggest generic pharmaceutical companies, we are a worldwide recognized name. Our world-class manufacturing facility, coupled with a brilliant team of pharmacists, works around the clock to assure the highest quality final product possible.

Consequently, we have received certification from the top agencies such as ISO 9001:2008, GMP, WHO, FDA, and others. We have a diverse product range in many areas of healthcare.

We have effectively expanded our reach to Asia, Africa, and the Middle East along with the home market. This consistent development may be attributed to our team members’ expertise, experience, responsibilities, hard work, and our founder’s guidance. The company has a cutting-edge manufacturing facility in Ahmedabad, Gujarat’s excise-free zone.

JoinHub Pharma, a reputable generic drug supplier for Syria, develops, manufactures, and markets generic and branded human medicines and active pharmaceutical components. We specialize in generic medications but sell active pharmaceutical components and, to a lesser extent, proprietary pharmaceuticals.

JoinHub Pharma creates and promotes high-quality generic products at reasonable rates, earning the company a name in many regions of the world. Our generic medications are based on our proprietary processes for manufacturing or isolating active pharmaceutical components and our own pharmaceutical formulations.

What makes us the greatest choice for a partner and customer in Syria? Here are some things to think about:

Featured in prestigious pharmaceutical magazines.
the latest packaging technology, such as ALU-ALU, is employed.
The Manufacturing Agreement is maintained transparently by clarifying the terms and circumstances. It also covers intellectual property rights, terms and fees for early termination, and payment terms and conditions.
We have a reputation for maintaining long-term relationships.
Largest selection of over 1200 pharmaceutical goods.
There are nine sections dedicated to various sectors of healthcare and medicines.
Skilled R&D team with highly equipped automated laboratory.
Manufacturing takes place in duty-free excise zones, making the business transaction more inexpensive.
Food and Drug Administration (FDA) certified pharmaceutical goods for all medications.
FSSAI and DCGI certification for all items.
Units and factories approved by reputable organizations such as the World Health Organization (WHO) and Good Manufacturing Practices (GMP) (GMP).
All clients’ generic medicine product formulations are kept confidential.
The business has handled the approval of an Abbreviated New Drug Application (ANDA) to sell a generic drug product.

What We Offer You as Generic Medicine Supplier, Manufacturers, and Exporter

JoinHub Pharma – the best Indian generic medicines supplier for Syria, has created numerous compounds to prepare about 1200+ dose combinations for generic medications. We use cutting-edge packaging technologies that guarantee that generic medications are good quality and cost-effective. We cover a wide range of medical topics such as cancer, derma, pediatrics, sexual wellness, fluid treatment, and so on. Our generic drugs fall into the following categories:

Tablets
Capsules
Injections
Ointment
Drops
Sachets
Lotions
Powders
Syrups

Our production occurs in WHO and GMP-certified facilities equipped with cutting-edge technology and machinery. Each production process is carried out with the highest accuracy and precision by precisely measuring the composition. As a result, if you pick us as generic pharmaceutical exporters, you can rest confident that you will receive the most authentic generics.

JoinHub Pharma’s Valuable Features

More than 25 countries

We have crisscrossed Asia Pacific, Latin America, the Middle East, Sri Lanka, Africa, CIS nations, and many more in a very short period of time.

1300+ product lines

We provide depth and diversity with over 1300 pharma products in over 20 categories.

Manufacturing Facility Certified by WHO-GMP

All of our pharmaceutical products are manufactured in WHO-GMP-certified factories to ensure the highest quality.

Turnaround time of 24 hours

We promise a 24-hour turnaround on all RFQs and have specialized staff for international commerce.

Collaborate with the finest Indian generic pharmaceutical provider in Syria

JoinHub Pharma, a prominent Indian generic meditation supplier, offers you a low-cost manufacturing business opportunity. All of our pharma products are of the highest quality. We guarantee the greatest formulation with our specialized divisions.

If you want to know more information regarding our generic medicine manufacturing process, you can Email us at [email protected].

We will be looking forward to hearing from you!

Generic Medicine

What’s the Difference? Biosimilar and Generic Drugs

by Join Hub Pharma on September 22, 2021

The primary issue with biosimilar drugs is that numerous doctors and patients cannot distinguish them from generic drugs. They tend to believe that both are just copies of the original or reference drug.

In fact, the survey created by PwC in December 2015 states that around 67% of consumers were not sure what a biosimilar was, and about 16% gave an incorrect answer to the question about what a biosimilar was.

Although both generic drugs and biosimilars have the same commercial basis, meaning they are marketed when the original drug’s patent has expired, they are two completely different products regarding their structure, development, and authorization. In this article, we’ll discuss the main differences between biosimilars and generic drugs as per leading generic medicine suppliers.

What Are Generics?

A generic drug is a type of medicine that contains the same API and has an equivalent therapeutic effect as the branded drug. These drugs are additionally identical in terms of safety, dosage, strength, quality, route of administration, intended use, form, quality, effect, and side effects. These drugs can be manufactured just after the branded drug’s patent expiration.

Many reputed generic pharma companies in India use some simple chemical structures that can be manufactured quickly as compared to biosimilars.

What Are Biosimilar Drugs?

A biosimilar is a biologic medical product that is highly similar to already certified biological drugs. They get approval as per the pharma quality, safety, and effectiveness standards apply to all biological medicines.

Just like generics, biosimilars products can’t be manufactured until the patent of the drug expires. Due to the natural variability and complex processing of biological drugs don’t permit duplication of the molecular micro-heterogeneity. Thus, a biosimilar isn’t regarded as a generic of biological medicine.

Difference Between the Biosimilar and Generic Drugs

Although both generic and biosimilars medicines have similar revenue goals and are only permitted to market when the original drug’s patent has expired, they are entirely different products when it comes to their development, structure, and authorization.

Here are a couple of main differences between generic and biosimilars drugs.

Biologic medicines are large and complicated molecules or compounds of molecules that may be formed of living material, while generic drugs are chemically synthesized.
Unlike generic drugs, the FDA demands a biosimilar to be highly similar but not very identical to the current biologic medicine or the reference product.
A biosimilar medicine should demonstrate no clinically meaningful differences in safety, efficacy, and potency with its reference product. It must be the same as the original biological medicine, while the generics are branded products.
The generic drug’s cost usually reaches 40% to 50% less than the branded products and biosimilars. On the other hand, it is more like 15% to 20% cheaper due to the generic pharmaceutical manufacturer’s cost of testing.
It is easy to create accurate generics copies of branded drugs, plus it requires no complicated modifications, making the drug manufacturing process smooth.
Like generic drugs, biosimilars and other reference drugs aren’t synthesized through an easy chemical synthetic reaction. They require a complicated process in a cellular environment, such as any protein from the body.
Almost all generic drugs require an investment of around 2-3 million dollars, but due to the complexity involved, biosimilars need an investment of around 3+ billion dollars.
Generic drugs can reach your desired market in 2 to 3 years, but a biosimilar drug needs approximately between 7 and 8 years to reach the market. This extended timeline for biosimilars is due to the numerous studies necessary for their authorization, including safety and efficacy studies compared to reference branded drugs.
Generic drugs must have bioequivalence studies in healthy volunteers but do not need preclinical studies. When it is marketed, they need the proper pharmacovigilance process.
Unlike generics, biosimilars are evaluated and certified under the FDA evaluation process called 351(k) pathway 2.

Why Are Organizations Looking for Generic and Biosimilar Markets?

The increasing danger of chronic diseases such as diabetes & cardiovascular diseases, the large geriatric population, increasing healthcare expenses contribute to the growth of the generic drug market and an increased number of branded drug patent expires.

Being a leading generic pharma company in India, we, at JoinHub Pharma, think of the other key factors such as:

Stringent governmental regulations and adverse effects linked with new drug development.
The increasing demand for newer versions of generic drugs
Many licensing and procedural strategies require to launch of new products by companies
In contrast with branded drugs, the generic drug’s manufacturing costs much less since they don’t need animal studies and clinical trials to show the efficacy and safety of the drug.
Due to the lowered upfront cost incurred in R&D, generics are usually marketed at a considerably lower price.

Investment and Cost of Development: Generic Vs. Biosimilar

Generally, generic drugs cost 40% to 50% less than the branded drug. On the other hand, Biosimilars are nearly 15% to 20% cheaper due to the generic pharmaceutical companies’ expense on testing.

Generic drugs need an investment of around 2-3 million dollars. However, biosimilars need a considerable investment of around 3 billion dollars due to the given complexity. Moreover, while a generic drug can touch the market within an approximate period of 2 to 3 years, a biosimilar drug requires between 7 and 8 years in order to be marketed. All this time required to develop biosimilars is due to the numerous studies necessary for their authorization, including pharmacokinetic studies.

JoinHub Pharma – The key Market Player

JoinHub Pharma is the biggest generic pharmaceutical company. The company is certified by the highest authority like WHO-GMP, EUGMP, FDA, MOH, etc. They are ranked in the top 10 generic pharmaceuticals companies in India and are known for high-quality pharma manufacturing products and services.

Get in touch with the experts at JoinHub Pharma today to know more about manufacturing generic and biosimilar drugs.

Why Are Generic Drugs Import

ant?

A generic drug is a pharma medicine equal to a brand-name product in strength, dosage, kinetics, way of treatment, quality, and its intended usage. It may additionally refer to any drug, which is promoted under its chemical name without advertising.

For approval to promote the standard drug, an abbreviated new drug application known as ANDA is to be submitted by the generic pharmaceutical companies.

High-quality generic drugs are essential since they are less expensive choices to their brand-name alternatives. The high usage and easy accessibility of generic drugs of branded medicines have an actual result in saving expenses for health care users.

Although generics are demanded to fill most medications, the actual costs connected with these prescriptions are less when compared to branded counterparts. Generic Drug Development is uniquely established to FDA safety assessments, post-marketing needs, and Pharmacovigilance efforts to help assure the sustained capability of the expert category.

Benefits of Generic Drugs:-

Patients Can Save Serious Money with Generic

How can this be? As per the FDA, generic drugs can cost are estimated about 85% less expensive than medicines designed to counterfeit. The studies show that branded drugs don’t have to be repeated with their bioequivalent generic replacement, assisting in cutting their cost dramatically.

Generic Drugs Can Be Just as Effective as alternate Branded drugs.

Generic drugs offered by a reputed generic medicine supplier are an efficacious and FDA-approved option for patients. Such medicines are identical to their brand-name equivalent in numerous categories, including dosage, strength, form, safety, quality, intended use, and performance properties. Thus, the generic drug is considered to be bioequivalent.

Patients Can Easily Find a Generic Equivalent

Patients do not want to investigate far to see alternatives to many popular branded drugs. There are many common medications with high-quality generic equivalents, as above 12,000 generic drugs are readily available to customers. For example, the allergy medication named Allegra can be exchanged with Fexofenadine. Warfarin can replace another famous blood-thinning drug called Coumadinrin.

Generic Drugs Help can Reduce Costs in the U.S. Health Care System

It is not only patients who benefit from high-quality generic drugs. Association for Approachable Medicines shared that in the past 10 years, the savings for the U.S. healthcare system from generic drugs is around $1.67 trillion.

As healthcare expenditures continue to increase, it is essential to contact the best generic pharmaceutical manufacturers for alternatives and make them readily available to patients. This may slow down the increase in health care expenses often passed along to patients.

Stay the Course with Generics

Patients are 3x times more likely to abandon branded prescriptions than their generic alternatives, and this abandonment is often directly related to high copays.

Generic drugs are an easy and affordable alternative for treating several people who have to take prescription drugs. They can increase the probability that patients follow through with doctor-recommended care.

Contact JoinHub Pharma – the biggest generic pharmaceutical company in India for placing bulk orders of generic drugs.

JoinHub Pharma

JoinHub Pharma is an award-winning Pharmaceutical Company in India. We hold a reputed name with regards to branded medicines and generic medicines. Our company is certified by the highest authority like WHO, FDA, ISO 9001:2008, GMP, etc. We are a top generic pharma manufacturer, supplier, and distributor in Latin America and are known for our top-of-the-line quality pharma products and services. Without a doubt, we are considered to be one of the best generic pharmaceutical companies in India.

In fact, 85% of our revenue is generated by way of exporting to MIDDLE EAST, CIS, and AFRICA production facilities. We are famous for our widest list of medicines which contains more than 1000+ pharma products.

Based in India, JoinHub Pharma is a generic pharma company in India with a broad footprint covering the US, Europe, South-East Asia, Middle East, and South Africa. It manufactures more than 200 generic drugs and complex APIs in a wide range of therapeutic areas, including cardiovascular, diabetes, HIV, oncology, infectious diseases, hepatitis, ophthalmology, urology, neurosciences, respiratory, and women’s health.

Dr. Reddy

The global generics segment of Dr. Reddy’s accounted for approximately 80% of the company’s revenue in 2018, with North America being the biggest contributor.

As of March 2018, the company filed 20 abbreviated new drug applications (ANDAs) and had 110 generic filings pending approval with the US FDA. Moreover, it launched five first-generic-to-launch (FGTL) products in Brazil.

Based in India, Dr. Reddy’s is an Indian pharmaceutical company whose generic formulations business offers more than 200 high-quality generic medicines worldwide, with over 20 assets falling under the complex generics category, including decitabine, fondaparinux, and azacitidine injections.

The company’s generic formulations segment includes tablets, capsules, injectables, and topical creams. Nise (Nimesulide), Stamlo (Amlodipine Besylate), Omez (Omeprazole), and Razo (Rabeprazole) are a couple of its products available in Latin America’s emerging markets.

Teva Pharmaceutical

Teva Pharmaceuticals’ 2018 revenues in North America decreased by 22% as compared to 2017 because of the price erosion and volume reductions. They have launched generic versions of medicines such as Solodyn®, Aloxi®, Syprine®, Estrace®, Lialda®, Uceris®, and Elidel® in the region in 2018.

The company’s European revenues increased by 4% to $3.6bn, compared to 2017. The revenue growth resulted from an increase in OTC medicine sales and the launch of new pharma products, which offset the impact of price cuts of generics in the first half of 2018. However, the overall revenue was affected marginally in the second half of 2018 because of the dismissal of Teva’s joint venture with PGT Healthcare.

Teva Pharmaceuticals offers diverse products in various segments such as specialty, generic, OTC, and APIs.

Cipla

Cipla’s revenues progressed marginally compared to the earlier year, with the generics business in Latin America contributing around 21% to the domestic business revenues as of March 2018.

The company was ranked as one of the top ten generic Pharma manufacturers in the US, with 13 out of 52 products ranked as number one, according to IQVIA IMS RQTR as of March 2018.

Cipla is working to develop complex generic formulations based on nanotechnology for the US market.

Lupin

Lupin’s generics business held 90% of the company’s total revenues in the US in 2018. It was established in 1968, and while its primary focus is generic drugs, it additionally produces branded medicines and API (active pharmaceutical ingredients).

Lupin filed 20 generic products in many geographic regions worldwide, which includes the APAC (Japan & Australia), Canada, EMEA (Europe, Middle East, and Africa), and Latin America (Brazil & Mexico), and got 22 approvals in 2018.

Lupin also got 24 ANDA approvals out of 36 ANDA files in the US in 2018.

Lupin is a pharma company based in India with many segments, including generic products, biotechnology products, complex generics, APIs, and specialty.

If you’re looking for generic medicines at an affordable rate, contact JoinHub Pharma – a leading generic pharma company in India.

Simply drop them an email at [email protected] or call directly on +91 97247 25604.

What is the Generic Pharmaceutical Manufacturing Industry in Latin America?

Generic medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Many generic drugs are manufactured, distributed, and supplied without patent protection, and industry operators are not even engaged in the R&D of new drugs.

The pharma industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

Which Are The Top Generic Pharma Companies In India?

The pharma companies holding the largest market share in the Generic Pharmaceutical Manufacturing in the US industry include JoinHub Pharma.

JoinHub Pharma is a leading generic pharmaceutical manufacturer, supplier, exporter in Latin America and offering services to pharmacies across the US. Now, you can streamline your pharma medicine purchasing and optimized your buying power by utilizing the comprehensive purchasing strategy offered by JoinHub Pharma. We manufacture, we deliver, and you save.

We are highly committed to making our pharma company your first and last call when you have a need for medicine export from India. You will find us valuable, friendly, and efficient for all your pharma needs.

Branded & Generic Medicine Distribution

JoinHub Pharma has a wide range of 10,000+ generic and branded medicines’ manufacturing and distribution services across India and is one of the top generic medicine distributors in Latin America, South Africa, and the Middle East. As a leading branded and generic medicine manufacturer and supplier in Latin America, we deal in all sorts of medicines, i.e., liquid, capsules, topical medicines, inhalers, tablets, suppositories, injections, implants or patches, buccal, drops, etc.

JoinHub Pharma provides branded and generic medicine distribution with national coverage across the country.

JoinHub Pharma offers its clients up-to-date pricing, inventory levels, and order status (hospitals, dispensaries, patients, pharmacies). With JoinHub Pharma, clients have access to:

Direct reach to 10,000+ branded & generic medical & health care products
Up-to-date branded & generic medicines and their reasonable pricing information
Simplified, intuitive, branded & generic medicine ordering
Branded & generic medicine manufacturing and distribution purchase history with detailed reporting

Our product as pharma Exporter India range includes HIV medicines, oncology, and other lifesaving generic medicines.

What We Offer You as Generic Medicine Manufacturer and Distributor?

JoinHub Pharmaceuticals has developed around 400 molecules that are being utilized in making around 1000 dosage combinations to prepare the generic medicine. We cover a wide range of healthcare products like derma, pediatric, cancer, fluid therapy, etc.

We use the latest packaging technology to ensure high-quality and cost-effective generic medicines. Our generic medicines are manufactured and supply under the following categories:

Tablets
Injections
Capsules
Ointment
Sachets
Powders
Syrups
Lotions

Our medicine manufacturing process occurs in WHO and GMP-certified pharmaceutical plants that are well-equipped with ultra-modern systems and machinery. Every single drug manufacturing step is carried out with 100% accuracy and precision by measuring the composition. Thus, you can be assured of getting the most genuine generics if you choose us as generic medicine exporters.

Our Role as Generic Medicine Suppliers in Latin America

Busy and fast modern lives give rise to a lot of health issues. These include headaches, body aches, colds, vitamin deficiency, and low energy levels. Apart from the common problems, life-threatening ailments like Cancer and HIV-AIDS are at their peak. The branded medicines designed to heal such ailments are costly, and one cannot afford them for a large section of society.

Therefore, it becomes increasingly important to promote alternate generic medicines. Besides having a similar effect as the branded ones, they are pocket-friendly and thus accessible for the masses. However, some pharma companies are producing low-quality generics to earn greater profits. This imposes a severe threat to the health of the patients and questions the integrity of the Pharma Community.

JoinHub Pharma separates itself from the rest of the pharma companies with its safe and genuine generic medicines. We maintain appropriate collaboration with the doctors and pharmacists to keep upgrading the manufactured pharma products. We understand that even a minor change in composition can hugely affect human lives. Our ultimate goal is to make high-quality generic medicines available at an affordable rate not only for Latin America but for the entire globe.

If you’re looking for a reliable pharmaceutical exporter from India with competitive pricing, please contact us for further information. You will be amazed by our reasonable prices & efficient service. Simply drop us an email at [email protected], and our experts will reach out to you within 24 hours.

Generic Medicine

Generic Medicine Suppliers Serving as World’s Pharmacy

by Join Hub Pharma on January 18, 2021

The need of India to produce a huge amount of generic drugs perfectly lines up with its aim to become the most promising bulk, generic drug exporter, to markets of Africa, Qatar, Thailand, etc. Giving importance to this context, the nation has to embrace the economy and focus on producing bulk drugs to give the toughest competition to China and other countries. The government and the private generic medicine supplier are adopting distinct policy measures to generate new formulations and export bulk drugs.

Pharmaceutical as a component:

The trade expansion strategy of India considers pharmaceutical as a key component. The country has an objective in respect to the wider diversification of the medicine export profile given consideration to destination and products.

The global demand of exporting drugs has risen and so the nation is pushing its focus mainly on pharmaceuticals. By 2030, the pharma industry of India is hoping to become the largest drug supplier of the world. The target is to touch a revenue of approximately $120-130 billion at c CAGR of 11-12%. Presently, it is $38 billion.

Posing as world’s pharmacy:

Experts opine that this nation is posing as the world’s pharmacy due to the supply of low priced high-quality drugs in different countries. Medicine exporters in Qatar and other locations order drugs in bulk on a regular basis. The estimation of the government says that India proudly holds the 3^rd rank globally for the production of pharmaceutical products by volume. Also, it holds 13^th rank in pharmaceutical production by value.

Pharmaceuticals exporters in Africa: Now

According to an estimation, Africa spends approximately $2 billion per year on the treatment of AIDS patients. The executive director of UNAIDS, Michel Sidibé opined that if India would not help, then Africa could not access the treatment of AIDS at $2 billion. Without the presence of India, the cost could reach around $150 billion which is excessively massive.

Additionally, pharmaceutical exporters in Africa or pharma manufacturer in Nigeria are considering tuberculosis and anti-malaria drugs from India. The cost is much less than the medicines supplied by European and US drug suppliers.

In 2015, pharmaceutical exporters in Africa took pharma products that worth around $4 billion. Each year, the generic drug market in Africa is growing at 25 to 30 per cent. The market depends mainly on importing generic drugs. Hence, the small, mid and good Indian pharmaceutical companies are grabbing this golden opportunity to expand the size and revenue.

Many times, the small pharmaceutical producers in India cannot match the stringent standards imposed by the authorities of Europe and the US. But, it is not the case with Africa, Nigeria, Tanzania, Madagascar, Mozambique, etc. So, the pharmaceutical companies in Nigeria, Africa, and etc. export bulk generic drugs and other pharma products from Indian companies.

Advantage India:

Among the top importers of pharma products from India, Nigeria, Qatar, Africa, Thailand, South Africa, USA, Russia, etc. hold prominent name.
Right now, generic medicine suppliers in India export around 20 to 22 percent of global export volume.
The cost of manufacturing is lower than half of Europe and the entire USA.

Indian pharma manufacturers and suppliers are helping relatively poorer nations like Africa, Nigeria, etc. to deal with tuberculosis, malaria, HIV, and other diseases like presently COVID issues through generic medicines that are low cost. The pharma manufacture in Nigeria is considering India as the key support to get the drugs in bulk for their people.

Thailand pharmaceutical manufacturers seeking India’s support:

Thailand is also wishing to get India’s support in the medical fields like pharmaceutical products and generic drugs. The top pharmaceutical companies in Thailand want to close the big gap between demand and supply of medical devices and pharmaceutical products. It is a major tourist spot. Besides, people from all over the world take treatments from here. India can efficiently fulfil the demands.

Ending with:

Pharma companies in Thailand or top 20 pharmaceutical companies in Nigeria, or any pharma manufacturers and exporters from other nations like Qatar, Africa, and others are depending on India for taking international brand names and generic medicines manufactured in this country. Certain awarded, accredited and trusted firms are ruling this field since long. These firms are committed to offering quality products to global clients.

They act as the one-stop solution for the entire pharmaceutical requirements without any compromise in quality and consistency. The WHO: GMP certified manufacturing plants ensure the products’ quality. The medicine exporters in Qatar, Thailand, Africa and other countries can easily contact these Indian firms online and discuss their requirements and objective. The private sectors and government of these countries are taking initiatives to strengthen the bond with India and exchange help. The authentic Indian firms are providing full value for money at each stage of pharmaceutical production and supply.

Generic Medicine

How COVID-19 Open up Opportunities for India’s Pharma Industry that Must Be Seized

by Join Hub Pharma on October 31, 2020

Given the magnitude of the COVID pandemic and its spread across the world, it seems to be almost certain by now how a post-coronavirus world will observe an altogether different ordering of the worldwide economic and political system of commitments and preferences.

If the Great Recession of 2008 united numerous nations in guaranteeing collective banking and financial sector reforms – to save an infectious spread in the financial sector – the 2020 worldwide pandemic shall ideally make the global commitments and needs of most nations more skewed towards guaranteeing more prominent public health security for its citizenry.

Up until this point, as the crisis is still unfolding, many critical multilateral arrangements in place – regardless of whether the G20 or G7 – have played a limited role in introducing a unified front or in reassuring and giving effective measures of relief to most affected nations.

The G2 ‘Great Powers Club’ too for example US and China, have confronted criticism for showing weak global leadership, as the pandemic has infected one country after another.

But what about India?

In comparison to other countries, say, China, Eurozone, or the United States, India has been both fortunate and cautious, in preventing the infectious spread of the virus in its domestic territory with early restrictions on mobility from different countries, seeking contact tracing, and declaring a lockdown early. It has likewise taken larger efforts as of late to send across medical supplies and drugs to different countries in need.

Assuming that the country takes all the important precautions ahead and keeps the infection curve trajectory more flattened, India has a decent opportunity to come out on the better side of the crisis. What’s more, that offers India a window of opportunity in this emergency.

So, how would India be able to utilize this crisis as an opportunity to reorder its own worldwide commitments and rise as a significant actor to permit more nations to become interdependent and associate with a huge developing market?

In a post-coronavirus global order, India’s similar favorable position can depend intensely on becoming a significant provider for global public goods and services, given how the demand for these are probably going to go up in years to come.

Here, we talk about the prospects in healthcare as a case in point.

India’s current preferred position of large-scale pharmaceutical production enables it to significantly leverage its soft power by investing in the outward growth of the healthcare sectors of different nations by:

Ramping up exports in drugs;
Turning into a preferred medical tourist destination for those looking for affordable treatment in quality secondary/tertiary health services,
Seek after medical diplomacy by offering medical training and technical expertise to many other developing nations whose healthcare systems are a lot worse than India.

Boosting pharma exports

As per the Indian Brand Equity Foundation (IBEF), pharmaceutical exports of India from the financial year 2012 to 2019 have consistently grown from $10 billion to $19 billion.

According to estimates, India represents about 10% of the world’s pharmaceutical production by volume and 1.5% by value. The industry is the world’s biggest supplier of generic drugs and controls around 18% of the worldwide market. It is additionally a leading producer of vaccines on the planet and caters to about 50% of worldwide vaccine demands.

This is because of the effective high demand for Indian drugs in light of cheaper pricing, making these more reasonable to both developing and developed nations.

Indeed, even with the breakout of the COVID-19 pandemic, many private Indian pharma manufacturers expressed their desire to expand their supply of required medications to these nations.

Not only states, however public health non-state actors and many international NGOs have been utilizing generic Indian drugs for affordable treatment in countries within Africa, parts of Latin America over the last decade.

Empowering medical tourism in India

Over the last few years, especially since 2014, the number of people coming to India for medical treatment has grown yearly at about 55%. As per the Ministry of Tourism, the medical tourism space was estimated at around $3 billion (US$) in 2015 and at $9 billion in 2020.

The Indian government has additionally advertised India as a superior medical tourist destination by giving fast-track medical visas and rapid airport clearances for those visiting as medical tourists. Although, most vital players in the medical tourism space are those in the private sector yet obviously it is clear that this is a space for the Indian government to develop significantly more capacity in years ahead.

Pursue medical diplomacy

In spite of India’s colossal steps in medical-value tourism and in the growth of pharmaceutical exports, it actually has a long road ahead to use its potential at a worldwide level. India’s own public-healthcare system appears in poor shape (excepting some of the states in the Southern and North-Eastern part of the nation). It has one of the most minimal doctor-to-population ratios in the world. The gains accrued have to a great extent been due to the asymmetric, privatized nature of the healthcare system in India-which has permitted the private sector to make inroads to other local/and global accomplices (in West Asia).

To project itself as a nation practicing medical diplomacy through soft-power, if there is one nation from which the Indian state can especially learn, is Cuba.

Regardless of being a small nation with a much lower per-capita income, Cuba’s public healthcare system is truly outstanding in the world. The Cuban State has polished a humanitarian goal of medical-internalization as a major aspect of its diplomatic mission and acquired a more extensive reputation and praise by offering doctors and medicines at times of health-emergencies in many nations in need. Its medical teams -sent in the state, have likewise maintained a longer presence in health emergencies prone areas around the globe with around 50000 doctors stationed abroad by 2018. In the recent past too, Cuba sent the biggest group of medical doctors to West Africa during the Ebola epidemic.

The communist state additionally embraced a diplomatic strategy of making bilateral agreements with countries like Argentina and Venezuela, to pay for offered medical services, while likewise guaranteeing medical aid to nations like Algeria and Haiti in times of war and different crises. Thus, this arrangement by the year 2018 brought about $11 billion in (medical) exports from Cuba while additionally financing its helpful efforts.

In a post-coronavirus world, healthcare would rise as a significant point of attention for some countries over the world. What’s more, in a reordered version of globalization, worldwide public goods like healthcare security will attract countries to look for partners with a more comparative advantage in providing for medical expertise for treatment, essential medications; and in-state capacity-building for medical-aid and service to different countries (as needed).

India can possibly do tremendously well in the first two of these areas (given its similar advantages in pharma-based exports and in medical tourism), for the third, in embedding state-diplomacy with medical-diplomacy and putting resources into its outreach, there should be a radical (re)orientation in our worldwide (diplomatic) priorities and duties, starting from territorial to international channels.

We at JoinHub Pharma – the leading pharmaceutical company in India manufacture high-quality, affordable branded and generic medicines. Contact us to discuss more pharma products.

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Generic Medicine Pharmaceutical Company

Do Generic Pharmaceutical Drugs Compromise on Quality?

by Join Hub Pharma on October 29, 2020

Nowadays due to increased health problems, and high medicinal expenses people have started making a shift to generic drugs which are the same as brand-name drugs and offer almost equivalent medicinal properties. Generic pharmaceutical companies have never been as famous as branded and marketed drug companies. So people always have a question regarding are generic drugs as safe as their branded counterparts and are they effective in treatments for severe health implications.

Generic drugs are identical counterparts of branded drugs and medicines manufactured by large corporations. When the patent of any particular brand-name drug expires, other smaller pharmaceutical companies manufacture a generic version of it and sell it in the open market. Generic drugs are relatively cheaper as the companies producing it do not have to invest much time and money into the research and development stage. Because a formulation is already available, everything the company then needs is just to manufacture it and get it approved by the FDA.

How does the FDA approve Generic Medicines?
If a company wants to get its generic drug approved with the FDA’s stamp, it must manufacture a drug that can be seen as a bioequivalent of the brand-name drug previously available. The FDA allows drug manufacturers to make a change in the active ingredients of medicine for up to 20% but top generic pharmaceutical companies do not go to that extent in making changes in the drug’s composition.

Moreover, generic manufacturers also do not need to go under vigorous drug tests as the data available with the FDA for previously used brand-name drugs is used as a result. Hence generic drugs are mostly passed with smaller test cycles and datasets. This does not raise a question about the effectiveness of the drug. The FDA chooses this course just to ensure that the drugs reach the patients speedily in the market.

Are generic drugs less effective?
Generic medicines are as effective as their brand-name substitutes. The FDA ensures that every drug being sold in the market is safe and effective for its consumers whether it is a brand-name drug or a generic drug. As we know generic drugs have almost identical medical formulation and are made using the same active ingredients used in the making of branded drugs, generic drugs are hence the effective and alternative solution to most branded drugs.

Generic drugs are also tested and reviewed thoroughly almost as same as their branded counterparts; hence consumers should not be worried about the drug’s effectiveness. The FDA also saves and publishes information regarding generic drugs for almost all types of critical diseases. Some people also think that generic drugs are cheaper as they are made by smaller companies with limited on-site production facilities but in contrast, the FDA makes sure that a generic drug manufacturing unit complies with all the norms laid down by the FDA for manufacturing of medicines and drugs. It isn’t always that only smaller companies manufacture generic drugs and sell them in the market, but research shows that almost 50% of all generic drugs manufactured come from big branded companies as companies always thrive to make their medicines available to consumers on a large scale.

How to identify Generic Drugs?
Some laws suggest guidelines for generic drugs; any generic drug cannot be made to look the same as its branded counterpart. However, differentiating between a brand-name drug and a generic drug is never a big hassle. Manufacturers, to comply with the statutory guidelines laid down by the FDA and other institutions; develop generic drugs that vary in packaging, naming, colors, shapes, sizes, and many more different dimensions.

Is a Generic Drug available for every other Branded Drug?
Branded drugs have patent protection for 20 years, which provides relief to a company that no other manufacturer can make the same drug and sell it in the market. However when a patent for a branded drug has expired or is about to expire other manufacturers can get consent from the FDA and start manufacturing the drug under the prescribed guidelines for generic drug manufacturing. It is somehow difficult to find generic drugs for brand medications that have been in the market for less than 20 years, as it comes under patent protection. However, a similar medication can be found if needed.

The Market’s Boom for Generic Drugs

Today numerous ailments have drugs with their prices sky-rocketing by the passage of time. Several insurance providers now approve and pay their insurance holders for opting into generic drugs. Generic drugs have now gained a higher level of trust from people and people consider them an effective option to switch from branded medicines. This has helped the generic drugs market to grow on a rapid scale for the last few years.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Generic Medicine Pharma Products

The Pros and Cons of Using Generic Drugs

by Join Hub Pharma on October 22, 2020

According to the Food and Drug Administration (FDA), generic drugs are biologically equivalent to brand name drugs in dosage form, strength, safety, route of administration, quality, performance characteristics, and intended use. Basically, a generic drug is a copycat of a brand name medication (made after the patent from the brand name has ended). They’re likewise typically a more affordable solution.

Generic drugs seem to be getting more and more famous when it comes to significant brand name drugs, including many medications related to heart health like blood pressure and statins medication.

In fact, a record 86% of prescriptions dispensed in 2017 were for generic drugs versus brand-name drugs as per the IQVIA, one of the world’s largest contract research organizations.

Yet, exactly how safe is generic drugs when it comes to staying heart healthy? Let’s take a look at some of the pros and cons of generic medication below.

Pros:

- Cheaper prices. The main reason so many people purchase generic drugs is that they are more cost-effective than brand name drugs. Brand name drugs require research and testing that take a lot of money and time, however, generic drugs only need to copy what as of now exists, saving them the cost and permitting the price to stay low.

- Biologically speaking, generic drugs should satisfy precise guidelines so that the same amount of active ingredient is conveyed to the body simultaneously, and utilized by the body, in the same way as the brand name product.

- FDA approved. The FDA sets severe guidelines and performs research on generic drugs to ensure that they are bioequivalent to the brand name.

- Heart Healthy. As indicated by a recent study, generic heart medications show the same medical outcomes as brand name medications.

Cons:

- Contamination. Generic drugs are frequently produced in factories in countries like China, India, or other areas with cheap labor and overhead. The conditions at these manufacturing plants have sometimes contaminated drugs, leading to recalls in the United States. To be reasonable, however, there have been a handful of situations where even US-based brand name drugs had similar issues although probably not nearly as frequently.

- As per the report by the Government Accountability Office, these foreign factories sometimes escape rigorous FDA inspections, dodge documentation of their practices, and don’t get follow-up monitoring even when genuine manufacturing or drug-handling problems have been recognized. Generally, only one manufacturer produces a brand name drug whereas a couple of manufacturers can produce a generic drug. While the FDA insists on the bioequivalence of the active medication, there sometimes can be unpretentious differences in the delivery system of the drug or non-active “fillers” for the drug. These distinctions rarely result in any clinically significant issue for the patient despite the fact that in rare cases a patient might have a sensitivity or intolerance to an alternate filler or delivery system.

- Mixing up the pills. As brand medications ordinarily have a consistent “branded” look to them that patients can get familiar and comfortable with, generics frequently don’t look as familiar or it isn’t as obvious what each pill seems to be. Moreover, when a prescription is refilled, if the drug is made by a different generic manufacturer and has a different appearance, this can prompt drug confusion and blunders or even patients not taking the pills they are recommended.

- Doctors remain divided. Many medical experts are still divided on the utilization of generic drugs for heart disease, leaving some lingering doubt in this area. Some particular medications including thyroid supplements and blood thinners have had evidence of genuine clinically meaningful issues when switching between brand and generic or between different generics.

More and more frequently patients discover their brand name prescription medication won’t be covered by their insurance plan or their co-pay is higher. Regularly, the insurer will offer a generic version at a co-pay that is less. Luckily, at this point, the vast majority of cardiac medications are accessible in the generic form with commonly no obvious problems for the vast majority of patients.

When patients start on a new medication that is easily available from a generic drug manufacturer, it is usually recommended starting with the generic form if there is no scientific agreement that the brand name version is any better. While usually, the patient will likewise save money directly, we all benefit from the total reduction in health care costs. If a patient has been on a brand medication and can save cash by adopting the generic formulation or even a more affordable brand of the same drug class, it typically should be possible without any ill effects but we believe it ultimately ought to be the patient’s choice after consulting with their physicians. Many patients prefer not to “rock the boat” and not make the switch. While that is not unreasonable, one needs to weigh whether it is worth the additional expense.

If you have any questions or concerns about taking a generic versus a brand-name medication, reach out to us at JoinHub Pharma.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

Category: Generic Medicine

Partner with a Leading Third-party Generic Medicine Manufacturer for Mongolia

Partner With An Award-Winning Quality Pharma Company | JoinHub Pharma

Generic Pharma Drugs Being Manufactured By JoinHub Pharma

Safe and Effective Generic Drug Manufacturing for Mongolia

Why choose JoinHub Pharma for Generic Medicine Manufacturing for Mongolia?

Partner With An Award-Winning Quality Pharma Company | JoinHub Pharma

Generic Pharma Drugs Being Manufactured By JoinHub Pharma

Safe and Effective Generic Drug Manufacturing for Mongolia

Why choose JoinHub Pharma for Generic Medicine Manufacturing for Mongolia?

Are generic prescriptions as safe and effective as brand-name prescriptions?

Benefits of importing Generic Medicine from Indian Generic Manufacturer, Exporter, Supplier for Ghana

Generic drugs are less expensive

Generic drugs are safe and effective as their branded replicas

Duplicated Drugs are a Trusted Substitute for Brand-Name Drugs

Your patients can readily discover generic substitutes

Solves insurance coverage issues

JoinHub Pharma – A leading Generic Drug Manufacturer, Exporter, and Supplier for Ghana

Why Choose JoinHub Pharma as the best Indian Generic Medicine Manufacturer and Supplier for Ghana?

Factors influencing affordability of medicine in Syria

Benefits of Generic Drugs

Generic medications can be just as effective as their brand-name counterparts.

Generic drugs can help patients save a lot of money.

Generic drugs contribute to lower healthcare costs.

Patients Can Easily Find a Generic Equivalent

Continue to Use Generics

JoinHub Pharma – Leading Generic medicine Manufacturer, Supplier, and Exporter

What makes us the greatest choice for a partner and customer in Syria? Here are some things to think about:

What We Offer You as Generic Medicine Supplier, Manufacturers, and Exporter

JoinHub Pharma’s Valuable Features

More than 25 countries

1300+ product lines

Manufacturing Facility Certified by WHO-GMP

Turnaround time of 24 hours

Collaborate with the finest Indian generic pharmaceutical provider in Syria

What Are Generics?

What Are Biosimilar Drugs?

Difference Between the Biosimilar and Generic Drugs

Why Are Organizations Looking for Generic and Biosimilar Markets?

Investment and Cost of Development: Generic Vs. Biosimilar

JoinHub Pharma – The key Market Player

You may also like to read these blogs:-

Why Are Generic Drugs Import

ant?

Benefits of Generic Drugs:-

Patients Can Save Serious Money with Generic

Generic Drugs Can Be Just as Effective as alternate Branded drugs.

Patients Can Easily Find a Generic Equivalent

Generic Drugs Help can Reduce Costs in the U.S. Health Care System

Stay the Course with Generics

You may also like to read these blogs:-

JoinHub Pharma

Dr. Reddy

Teva Pharmaceutical

Cipla

Lupin

You may also like to read these blogs:-

What is the Generic Pharmaceutical Manufacturing Industry in Latin America?

Which Are The Top Generic Pharma Companies In India?

Branded & Generic Medicine Distribution

What We Offer You as Generic Medicine Manufacturer and Distributor?

Our Role as Generic Medicine Suppliers in Latin America

JoinHub Pharma - WHOGMP EUGMP Pharmaceuticals & Nutraceuticals Manufacturer exports products to the following continents